Delivery Order SPE2DB25D3306-SPE2DB25FUBRL

Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,003.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug Trulicity, a medication used to treat diabetes. The delivery order has a period of performance through May 14, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,501.50 Firm Fixed Price Delivery Order is for the provision of the drug Trulicity, a medication used to manage diabetes. The contract has an ultimate completion date of December 5, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity, a medication used to treat diabetes, with a ceiling value of $1,163.36 and a period of performance through April 2025. The contract is not set aside and is awarded under a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,380.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Trulicity, a diabetes medication, with a performance period through May 2025. This contract is not set aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $5,761.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1.5 mg/0.5 ml Trulicity pens, a drug used to treat diabetes. The award has an ultimate completion date of May 14, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $2,102.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity, a diabetes medication, with an ultimate completion date of April 24, 2025. The contract is a delivery order, with a firm fixed-price pricing type, and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,801.80 firm fixed-price delivery order is for the drug Trulicity, a medication used to treat diabetes. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 21, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,483.36 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a prescription medication used to manage diabetes. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,484.88 firm fixed-price delivery order covers the supply of the drug Trulicity, a medication used for the treatment of diabetes. The contract has an ultimate completion date of October 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the medication Trulicity, a prescription drug used to manage diabetes. The award has a ceiling value of $1,081.92 and an ultimate completion date of November 24, 2021. The contract is a firm-fixed-price arrangement and did not utilize a set-aside designation,...
  • SPE2DB25D3306
    Indefinite Delivery Contract
  • SPE2DB25D3306-SPE2DB25FUBRL
    Delivery Order

This is a $3,707.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the drug Trulicity, a treatment for diabetes, with a delivery period ending on May 13, 2025. This award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. This award does not have a set-aside designation, indicating open competition.

Generated 8/17/25, 12:44 AM